Daniel da Costa

Daniel Da Costa has a diverse work experience in the field of clinical science. Daniel is currently working at Day One Biopharmaceuticals as the Director of Clinical Science, a role they have held since February 2022. Prior to this, they worked at Day One Biopharmaceuticals as the Associate Director of Clinical Science from April 2021 to February 2022.

Before joining Day One Biopharmaceuticals, Daniel worked at AbbVie where they held the position of Associate Scientific Director from November 2018 to April 2021. Daniel also briefly served as a Clinical Scientist II at AbbVie Stemcentrx from June 2018 to November 2018.

Daniel's work experience also includes a position as a Clinical Scientist I at Stemcentrx, Inc. from April 2016 to June 2018. Daniel started their career at Roche, where they completed a PharmD Fellowship specializing in Clinical Science from July 2014 to April 2016.

Daniel Da Costa has pursued their education in a chronological manner. Daniel started by earning a Bachelor of Science degree in an unspecified field at UC Santa Barbara. Daniel then proceeded to the University of the Pacific, where they attained a Doctor of Pharmacy (Pharm.D.) degree. After completing their Pharm.D., Daniel pursued a PharmD fellowship at Rutgers University, focusing on clinical science and translational medicine. However, no specific start and end years are provided for any of these educational experiences.